Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 35, 2020 - Issue 1
Submit an article Journal homepage
4,482
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Recent advances in modulators of circadian rhythms: an update and perspective

Shenzhen HuangHenan Eye Institute, Henan Eye Hospital and Henan Key Laboratory of Ophthalmology and Visual Science, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University, Zhengzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-2711-146XView further author information
ORCID Icon,
Xinwei JiaoHenan Eye Institute, Henan Eye Hospital and Henan Key Laboratory of Ophthalmology and Visual Science, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University, Zhengzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-1815-5399View further author information
ORCID Icon,
Dingli LuHenan Eye Institute, Henan Eye Hospital and Henan Key Laboratory of Ophthalmology and Visual Science, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University, Zhengzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-0061-7604View further author information
ORCID Icon,
Xiaoting PeiHenan Eye Institute, Henan Eye Hospital and Henan Key Laboratory of Ophthalmology and Visual Science, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University, Zhengzhou, ChinaORCID Iconhttps://orcid.org/0000-0001-7342-7572View further author information
ORCID Icon,
Di QiHenan Eye Institute, Henan Eye Hospital and Henan Key Laboratory of Ophthalmology and Visual Science, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University, Zhengzhou, ChinaORCID Iconhttps://orcid.org/0000-0001-5846-1406View further author information
ORCID Icon &
Zhijie LiHenan Eye Institute, Henan Eye Hospital and Henan Key Laboratory of Ophthalmology and Visual Science, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University, Zhengzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3186-144XView further author information
ORCID Icon
Pages 1267-1286 | Received 13 Mar 2020, Accepted 08 May 2020, Published online: 08 Jun 2020

References

  • Takahashi JS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet 2017;18:164–79.
  • Bell-Pedersen D, Cassone VM, Earnest DJ, et al. Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet 2005;6:544–56.
  • Lopez R, Barateau L, Dauvilliers Y. [Normal organization of sleep and its changes during life]. Rev Prat 2019;69:537–45.
  • Abbott SM, Reid KJ, Zee PC. Circadian Rhythm Sleep-Wake Disorders. Psychiatr Clin North Am 2015;38:805–23.
  • Challet E. The circadian regulation of food intake. Nat Rev Endocrinol 2019;15:393–405.
  • Smolensky MH, Hermida RC, Portaluppi F. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev 2017;33:4–16.
  • Massin MM, Maeyns K, Withofs N, et al. Circadian rhythm of heart rate and heart rate variability. Arch Dis Child 2000;83:179–82.
  • Sim SY, Joo KM, Kim HB, et al. Estimation of Circadian Body Temperature Rhythm Based on Heart Rate in Healthy, Ambulatory Subjects. IEEE J Biomed Health Inform 2017;21:407–15.
  • Touitou Y, Mauvieux B, Reinberg A, et al. Disruption of the circadian period of body temperature by the anesthetic propofol. Chronobiol Int 2016;33:1247–54.
  • Refinetti R, Kenagy GJ. Circadian rhythms of body temperature and locomotor activity in the antelope ground squirrel, Ammospermophilus leucurus. J Therm Biol 2018;72:67–72.
  • Yamaguchi Y, Suzuki T, Mizoro Y, et al. Mice genetically deficient in vasopressin V1a and V1b receptors are resistant to jet lag. Science 2013;342:85–90.
  • Huang Y, Xu C, He M, et al. Saliva cortisol, melatonin levels and circadian rhythm alterations in Chinese primary school children with dyslexia. Medicine (Baltimore) 2020;99:e19098.
  • Reinke H, Asher G. Crosstalk between metabolism and circadian clocks. Nat Rev Mol Cell Biol 2019;20:227–41.
  • Shostak A. Circadian Clock, Cell Division, and Cancer: From Molecules to Organism. Int J Mol Sci 2017;18:873.
  • Gaucher J, Montellier E, Sassone-Corsi P. Molecular Cogs: Interplay between Circadian Clock and Cell Cycle. Trends Cell Biol 2018;28:368–79.
  • Hirota T, Fukada Y. Resetting Mechanism of Central and Peripheral Circadian Clocks in Mammals. Zool. Sci 2004;21:359–68.
  • Ralph MR, Foster RG, Davis FC, et al. Transplanted suprachiasmatic nucleus determines circadian period. Science 1990;247:975–8.
  • Cha HK, Chung S, Lim HY, et al. Small Molecule Modulators of the Circadian Molecular Clock With Implications for Neuropsychiatric Diseases. Front Mol Neurosci 2018;11:496.
  • Chen Z, Yoo SH, Takahashi JS. Development and therapeutic potential of small-molecule modulators of circadian systems. Annu Rev Pharmacol Toxicol 2018;58:231–52.
  • Froy O, Miskin R. The interrelations among feeding, circadian rhythms and ageing. Prog Neurobiol 2007;82:142–50.
  • Saito M, Murakami E, Suda M. Circadian rhythms in disaccharidases of rat small intestine and its relation to food intake. Biochim Biophys Acta 1976;421:177–79.
  • Fernández MP, Berni J, Ceriani MF. Circadian remodeling of neuronal circuits involved in rhythmic behavior. PLoS Biol 2008;6:e69–e69.
  • Tomioka K, Matsumoto A. A comparative view of insect circadian clock systems. Cell Mol Life Sci 2010;67:1397–406.
  • Gangwisch JE. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obe Rev 2009;10:37–45.
  • Oishi K, Miyazaki K, Kadota K, et al. Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes. J Biol Chem 2003;278:41519–27.
  • Yamazaki S, Numano R, Abe M, et al. Resetting central and peripheral circadian oscillators in transgenic rats. Science 2000;288:682–5.
  • Yoo SH, Yamazaki S, Lowrey PL, et al. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. U.S.A 2004;101:5339–46.
  • Takahashi JS. Molecular components of the circadian clock in mammals. Diabetes Obes Metab 2015;17:6–11.
  • Liu AC, Lewis WG, Kay SA. Mammalian circadian signaling networks and therapeutic targets. Nat Chem Biol 2007;3:630–9.
  • Kojima S, Shingle DL, Green CB. Post-transcriptional control of circadian rhythms. J Cell Sci 2011;124:311–20.
  • Gallego M, Virshup DM. Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol 2007;8:139–48.
  • Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002;418:935–41.
  • Preitner N, Damiola F, Zakany J, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002;110:251–60.
  • Cermakian N, Sassone-Corsi P. Multilevel regulation of the circadian clock. Nat Rev Mol Cell Biol 2000;1:59–67.
  • Meng Q-J, Logunova L, Maywood ES, et al. Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron 2008;58:78–88.
  • Asher G, Gatfield D, Stratmann M, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008;134:317–28.
  • Maury E, Hong H, Bass JJD. Circadian disruption in the pathogenesis of metabolic syndrome. Diabetes Metab 2014;40:338–46.
  • Gale JE, Cox HI, Qian J, et al. Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction. J Biol Rhythms 2011;26:423–33.
  • Shanmugam V, Wafi A, Al-Taweel N, et al. Disruption of circadian rhythm increases the risk of cancer, metabolic syndrome and cardiovascular disease. Global Health Sci 2013;2013:1–42.
  • Jiang T, Ji S, Yang G, et al. [Research advances in relationship between biological clock and cardiovascular diseases]. Sheng Li Xue Bao 2019;71:783–91.
  • Yu D, Fang X, Xu Y, et al. Rev-erbα can regulate the NF-κB/NALP3 pathway to modulate lipopolysaccharide-induced acute lung injury and inflammation. Int Immunopharmacol 2019;73:312–20.
  • Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003;3:350–61.
  • Sulli G, Lam M, Panda S. Interplay between circadian clock and cancer: new frontiers for cancer treatment. Trends Cancer 2019;5:475–94.
  • Shafi AA, Knudsen KE. Cancer and the Circadian Clock. Cancer Res 2019;79:3806–14.
  • Haspel J. Mind your bedtime: The circadian clock and mTOR in an orphan brain disease. Sci Transl Med 2017;9:aao2261.
  • Leng Y, Musiek ES, Hu K, et al. Association between circadian rhythms and neurodegenerative diseases. Lancet Neurol 2019;18:307–18.
  • Weintraub Y, Cohen S, Chapnik N, et al. Does the circadian clock have a role in the pathogenesis of inflammatory bowel disease (IBD)?. J Crohns Colitis 2018; 12:S270–S71.
  • Scheiermann C, Gibbs J, Ince L, et al. Clocking in to immunity. Nat Rev Immunol 2018;18:423–37.
  • He B, Chen Z. Molecular targets for small-molecule modulators of circadian clocks. Curr Drug Metab 2016;17:503–12.
  • Cyr P, Bronner SM, Crawford JJ. Recent progress on nuclear receptor RORγ modulators. Bioorg Med Chem Lett 2016;26:4387–93.
  • Tamai TK, Nakane Y, Ota W, et al. Identification of circadian clock modulators from existing drugs. EMBO Mol Med 2018;10:e8724.
  • Hirota T, Lee JW, John PCS, et al. Identification of small molecule activators of cryptochrome. Science 2012;337:1094–97.
  • Nangle S, Xing W, Zheng N. Crystal structure of mammalian cryptochrome in complex with a small molecule competitor of its ubiquitin ligase. Cell Res 2013;23:1417–19.
  • Hirano A, Braas D, Fu Y-H, et al. FAD regulates CRYPTOCHROME protein stability and circadian clock in mice. Cell Rep 2017;19:255–66.
  • Lee JW, Hirota T, Kumar A, et al. Development of Small-Molecule Cryptochrome Stabilizer Derivatives as Modulators of the Circadian Clock . ChemMedChem 2015;10:1489–97.
  • Oshima T, Yamanaka I, Kumar A, et al. C-H Activation Generates Period-Shortening Molecules That Target Cryptochrome in the Mammalian Circadian Clock. Angew Chem Int Ed Engl 2015;54:7193–97.
  • Chun SK, Jang J, Chung S, et al. Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock. ACS Chem. Biol 2014;9:703–10.
  • Humphries PS, Bersot R, Kincaid J, et al. Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents. Bioorg Med Chem Lett 2018;28:293–97.
  • Miller S, Son YL, Aikawa Y, et al. Isoform-selective regulation of mammalian cryptochromes. Nat Chem Bio 2020;16:676–85.
  • Raghuram S, Stayrook KR, Huang P, et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol 2007;14:1207–13.
  • Yin L, Wu N, Curtin JC, et al. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 2007;318:1786–89.
  • Pardee KI, Xu X, Reinking J, et al. The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBbeta. PLoS Biol 2009;7:e43.
  • Matta-Camacho E, Banerjee S, Hughes TS, et al. Structure of REV-ERBβ ligand-binding domain bound to a porphyrin antagonist. J Biol Chem 2014;289:20054–66.
  • Meng QJ, McMaster A, Beesley S, et al. Ligand modulation of REV-ERBalpha function resets the peripheral circadian clock in a phasic manner. J Cell Sci 2008;121:3629–35.
  • Kumar N, Solt LA, Wang Y, et al. Regulation of adipogenesis by natural and synthetic REV-ERB ligands. Endocrinology 2010;151:3015–25.
  • Grant D, Yin L, Collins JL, et al. GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα. ACS Chem Biol 2010;5:925–32.
  • Solt LA, Wang Y, Banerjee S, et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 2012;485:62–8.
  • Trump RP, Bresciani S, Cooper AW, et al. Optimized chemical probes for REV-ERBα. J. Med. Chem 2013;56:4729–37.
  • Shin Y, Noel R, Banerjee S, et al. Small molecule tertiary amines as agonists of the nuclear hormone receptor Rev-erbα. Bioorg Med Chem Lett 2012;22:4413–17.
  • Noel R, Song X, Shin Y, et al. Synthesis and SAR of tetrahydroisoquinolines as Rev-erbα agonists. Bioorg Med Chem Lett 2012;22:3739–42.
  • Lee J, Lee S, Chung S, et al. Identification of a novel circadian clock modulator controlling BMAL1 expression through a ROR/REV-ERB-response element-dependent mechanism. Biochem. Biophys. Res. Commun 2016;469:580–86.
  • Kojetin D, Wang Y, Kamenecka TM, et al. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem Biol 2011;6:131–34.
  • De Mei C, Ercolani L, Parodi C, et al. Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells. Oncogene 2015;34:2597–2608.
  • Torrente E, Parodi C, Ercolani L, et al. Synthesis and in vitro anticancer activity of the first class of dual inhibitors of REV-ERBβ and autophagy. J. Med. Chem 2015;58:5900–15.
  • Pariollaud M, Gibbs J, Hopwood T, et al. Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation. J Clin Invest 2018;128:2281–96.
  • Hering Y, Berthier A, Duez H, et al. Development and implementation of a cell-based assay to discover agonists of the nuclear receptor REV-ERBα. J Biol Methods 2018;5:e94
  • Amador A, Huitron-Resendiz S, Roberts AJ, et al. Pharmacological targeting the REV-ERBs in sleep/wake regulation. PloS One 2016;11:e0162452.
  • Banerjee S, Wang Y, Solt LA, et al. Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour. Nat Commun 2014;5:5759
  • Amador A, Kamenecka TM, Solt LA, et al. REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009. Biochem. Pharmacol 2018;150:1–8.
  • Cho H, Zhao X, Hatori M, et al. Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature 2012;485:123–27.
  • Mazzarino M, Rizzato N, Stacchini C, et al. A further insight into the metabolic profile of the nuclear receptor Rev-erb agonist, SR9009. Drug Test Anal 2018;10:1670–81.
  • Zhang L, Zhang R, Tien C-L, et al. REV-ERBα ameliorates heart failure through transcription repression. JCI Insight 2017;2:e95177.
  • Ercolani L, Ferrari A, De Mei C, et al. Circadian clock: time for novel anticancer strategies?. Pharmacol Res 2015;100:288–95.
  • Sulli G, Rommel A, Wang X, et al. Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence. Nature 2018;553:351–355.
  • Sitaula S, Billon C, Kamenecka TM, et al. Suppression of atherosclerosis by synthetic REV-ERB agonist. Biochem Bioph Res Co 2015;460:566–71.
  • Hwang J, Jiang A, Fikrig E. Rev-erb agonist inhibits chikungunya and O’nyong’nyong virus replication. Open Forum Infect Dis 2018; 5:ofy315.
  • Chang C, Loo C-S, Zhao X, et al. The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune disease. Proc Natl Acad Sci USA 2019;116:18528–36.
  • Dierickx P, Emmett MJ, Jiang C, et al. SR9009 has REV-ERB-independent effects on cell proliferation and metabolism. Proc Natl Acad Sci USA 2019;116:12147–52.
  • Zhao L, Isayama K, Chen H, et al. The nuclear receptor REV-ERBα represses the transcription of growth/differentiation factor 10 and 15 genes in rat endometrium stromal cells. Physiol Rep 2016;4:e12663.
  • Dong D, Sun H, Wu Z, et al. A validated ultra-performance liquid chromatography-tandem mass spectrometry method to identify the pharmacokinetics of SR8278 in normal and streptozotocin-induced diabetic rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci 2016;1020:142–47.
  • Gagnidze K, Hajdarovic KH, Moskalenko M, et al. Nuclear receptor REV-ERBα mediates circadian sensitivity to mortality in murine vesicular stomatitis virus-induced encephalitis. Proc Natl Acad Sci USA 2016;113:5730–35.
  • Chung S, Lee EJ, Yun S, et al. Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation. Cell 2014;157:858–68.
  • Welch RD, Billon C, Valfort A-C, et al. Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle. Sci Rep 2017;7:17142.
  • Kallen JA, Schlaeppi J-M, Bitsch F, et al. X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 2002;10:1697–707.
  • Kallen J, Schlaeppi J-M, Bitsch F, et al. Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A. J. Biol. Chem 2004;279:14033–38.
  • Kojetin DJ, Burris TP. REV-ERB and ROR nuclear receptors as drug targets. Nat Rev Drug Discov 2014;13:197–216.
  • Marciano DP, Chang MR, Corzo CA, et al. The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARγ, RORs, and Rev-erbs. Cell Metab 2014;19:193–208.
  • Stehlin C, Wurtz JM, Steinmetz A, et al. X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. Embo J 2001;20:5822–31.
  • Stehlin-Gaon C, Willmann D, Zeyer D, et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat. Struct. Biol 2003;10:820–25.
  • Jin L, Martynowski D, Zheng S, et al. Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma. Mol Endocrinol 2010;24:923–29.
  • He B, Nohara K, Park N, et al. The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome. Cell Metab 2016;23:610–21.
  • Chen Z, Yoo S-H, Park Y-S, et al. Identification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screening. Proc Natl Acad Sci USA 2012;109:101–06.
  • Kumar N, Solt LA, Conkright JJ, et al. The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol Pharmacol 2010;77:228–36.
  • Schultz JR, Tu H, Luk A, et al. Role of LXRs in control of lipogenesis. Genes Dev 2000;14:2831–38.
  • Wang Y, Kumar N, Nuhant P, et al. Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ. ACS Chem Biol 2010;5:1029–34.
  • Solt LA, Kumar N, Nuhant P, et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 2011;472:491–4.
  • Kumar N, Kojetin DJ, Solt LA, et al. Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist. ACS Chem. Biol 2011;6:218–22.
  • Kumar N, Lyda B, Chang MR, et al. Identification of SR2211: a potent synthetic RORγ-selective modulator. ACS Chem. Biol 2012;7:672–77.
  • Huh JR, Englund EE, Wang H, et al. Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors. Acs Med Chem Lett 2013;4:79–84.
  • Kotoku M, Maeba T, Fujioka S, et al. Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold. J Med Chem 2019;62:2837–42.
  • Zhang Y, Wu X, Xue X, et al. Discovery and characterization of XY101, a potent, selective, and orally bioavailable RORγ inverse agonist for treatment of castration-resistant prostate cancer. J Med Chem 2019;62:4716–30.
  • Bronner SM, Zbieg JR, Crawford JJ. RORγ antagonists and inverse agonists: a patent review. Expert Opin Ther Pat 2017;27:101–12.
  • Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science 2002;298:1912–34.
  • Reischl S, Kramer AJ. Kinases and phosphatases in the mammalian circadian clock. FEBS Lett 2011;585:1393–99.
  • Eide EJ, Woolf MF, Kang H, et al. Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol Cell Biol 2005;25:2795–807.
  • Vanselow K, Vanselow JT, Westermark PO, et al. Differential effects of PER2 phosphorylation: molecular basis for the human familial advanced sleep phase syndrome (FASPS). Genes Dev 2006;20:2660–72.
  • Mosser EA, Chiu CN, Tamai TK, et al. Identification of pathways that regulate circadian rhythms using a larval zebrafish small molecule screen. Sci Rep 2019;9:12405
  • Ono A, Sato A, Fujimoto KJ, et al. 3,4-Dibromo-7-Azaindole Modulates Arabidopsis Circadian Clock by Inhibiting Casein Kinase 1 Activity. Plant Cell Physiol 2019;60:2360–68.
  • Lee H, Lee JW. The Roles of CKI in Circadian Rhythm. Future Med Chem 2019;11:2621–24.
  • Reischl S, Vanselow K, Westermark PO, et al. Beta-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics. J Biol Rhythms 2007;22:375–86.
  • Meng Q-J, Maywood ES, Bechtold DA, et al. Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proc Natl Acad Sci USA 2010;107:15240–45.
  • Lee JW, Hirota T, Peters EC, et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl 2011;50:10608–11.
  • Hirota T, Lewis WG, Liu AC, et al. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta. Proc Natl Acad Sci USA 2008;105:20746–51.
  • Uehara TN, Mizutani Y, Kuwata K, et al. Casein kinase 1 family regulates PRR5 and TOC1 in the Arabidopsis circadian clock. Proc Natl Acad Sci USA 2019;116:11528–36.
  • Isojima Y, Nakajima M, Ukai H, et al. CKIepsilon/delta-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock. Proc Natl Acad Sci USA 2009;106:15744–9.
  • Kwak Y, Jeong J, Lee S, et al. Cyclin-dependent kinase 5 (Cdk5) regulates the function of CLOCK protein by direct phosphorylation. J Biol Chem 2013;288:36878–89.
  • Nakahata Y, Kaluzova M, Grimaldi B, et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008;134:329–40.
  • Chang HC, Guarente L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 2013;153:1448–60.
  • Sun S, Liu Z, Feng Y, et al. Sirt6 deacetylase activity regulates circadian rhythms via Per2. Biochem Biophys Res Commun 2019;511:234–38.
  • Bellet MM, Nakahata Y, Boudjelal M, et al. Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1. Proc Natl Acad Sci USA 2013;110:3333–8.
  • Wang N, Yang G, Jia Z, et al. Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1. Cell Metab 2008;8:482–91.
  • Onishi Y, Kawano Y. Rhythmic binding of Topoisomerase I impacts on the transcription of Bmal1 and circadian period. Nucleic Acids Res 2012;40:9482–92.
  • Moore-Ede MC. Jet lag, shift work, and maladaption. Physiology 1986;1:156–60.
  • Choy M, Salbu RL. Jet lag: current and potential therapies. P T 2011;36:221–31.
  • Mahoney MM. Shift work, jet lag, and female reproduction. Int J Endocrinol 2010;2010:813764–64.
  • Kelly RM, Healy U, Sreenan S, et al. Clocks in the clinic: circadian rhythms in health and disease. Postgrad Med J 2018;94:653–58.
  • Bollinger T, Schibler U. Circadian rhythms - from genes to physiology and disease. Swiss Med Wkly 2014;144:w13984w84.
  • Karatsoreos IN. Effects of circadian disruption on mental and physical health. Curr Neurol Neurosci Rep 2012;12:218–25.
  • Arble DM, Ramsey KM, Bass J, et al. Circadian disruption and metabolic disease: findings from animal models. Best Pract Res Clin Endocrinol Metab 2010;24:785–800.
  • Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science (New York, N.Y.) 2005;308:1043–45.
  • Rudic RD, McNamara P, Curtis A-M, et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol 2004;2:e377–e77.
  • Le Martelot G, Claudel T, Gatfield D, et al. REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis . PLoS Biol 2009;7:e1000181
  • Cook DN, Kang HS, Jetten AM. Retinoic Acid-Related Orphan Receptors (RORs): Regulatory Functions in Immunity, Development, Circadian Rhythm, and Metabolism. Nucl Receptor Res 2015;2:101185.
  • Hamilton BA, Frankel WN, Kerrebrock AW, et al. Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature 1996;379:736–39.
  • Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest 2005;115:1627–35.
  • Solt LA, Kojetin DJ, Burris TP. The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasis. Future Med Chem 2011;3:623–38.
  • Hirota T, Lee JW, St John PC, et al. Identification of small molecule activators of cryptochrome. Science (New York, N.Y.) 2012;337:1094–97.
  • Nohara K, Nemkov T, D’Alessandro A, et al. Coordinate Regulation of Cholesterol and Bile Acid Metabolism by the Clock Modifier Nobiletin in Metabolically Challenged Old Mice. Int J Mol Sci 2019;20:4281.
  • Nohara K, Mallampalli V, Nemkov T, et al. Nobiletin fortifies mitochondrial respiration in skeletal muscle to promote healthy aging against metabolic challenge. Nat Commun 2019;10:3923
  • Sehgal A, Mignot E. Genetics of sleep and sleep disorders. Cell 2011;146:194–207.
  • Kiessling S, Eichele G, Oster H. Adrenal glucocorticoids have a key role in circadian resynchronization in a mouse model of jet lag. J Clin Invest 2010;120:2600–09.
  • Yamaguchi Y, Suzuki T, Mizoro Y, et al. Mice genetically deficient in vasopressin V1a and V1b receptors are resistant to jet lag. Science (New York, N.Y.) 2013;342:85–90.
  • Jones CR, Huang AL, Ptáček LJ, et al. Genetic basis of human circadian rhythm disorders. Exp Neurol 2013;243:28–33.
  • Canales MT, Holzworth M, Bozorgmehri S, et al. Clock gene expression is altered in veterans with sleep apnea. Physiol Genomics 2019;51:77–82.
  • LeGates TA, Fernandez DC, Hattar S. Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci 2014;15:443–54.
  • Felder-Schmittbuhl M-P, Buhr ED, Dkhissi-Benyahya O, et al. Ocular Clocks: Adapting Mechanisms for Eye Functions and Health. Invest Ophthalmol Vis Sci 2018;59:4856–70.
  • Kondratov RV, Kondratova AA, Gorbacheva VY, et al. Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev 2006;20:1868–73.
  • Yang G, Chen L, Grant GR, et al. Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival. Sci Transl Med 2016;8:324ra16
  • Baba K, Ribelayga CP, Michael Iuvone P, et al. The Retinal Circadian Clock and Photoreceptor Viability. Adv Exp Med Biol 2018;1074:345–50.
  • Bhatwadekar AD, Yan Y, Qi X, et al. Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow. Diabetes 2013;62:273–82.
  • Leske MC, Connell AM, Wu SY, et al. Incidence of open-angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group. Arch Ophthalmol 2001;119:89–95.
  • Jean-Louis G, Zizi F, Lazzaro DR, et al. Circadian rhythm dysfunction in glaucoma: A hypothesis. J Circadian Rhythms 2008;6:1
  • Mure LS, Le HD, Benegiamo G, et al. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science (New York, N.Y.) 2018;359:eaao0318.
  • Lu D, Lin C, Jiao X, et al. Short-term High Fructose Intake Reprograms the Transcriptional Clock Rhythm of the Murine Extraorbital Lacrimal Gland. Invest Ophthalmol Vis Sci 2019;60:2038–48.
  • Jiao X, Wu M, Lu D, et al. Transcriptional Profiling of Daily Patterns of mRNA Expression in the C57BL/6J Mouse Cornea. Curr Eye Res 2019;44:1054–66.
  • Xue Y, Liu P, Wang H, et al. Modulation of Circadian Rhythms Affects Corneal Epithelium Renewal and Repair in Mice. Invest Ophthalmol Vis Sci 2017;58:1865–74.
  • Downton P, Early JO, Gibbs JE. Circadian rhythms in adaptive immunity. Immunology 2020; Online ahead of print.
  • Mendoza J, Vanotti G. Circadian neurogenetics of mood disorders. Cell Tissue Res 2019;377:81–94.
  • Hühne A, Welsh DK, Landgraf D. Landgraf D Prospects for circadian treatment of mood disorders. Ann Med 2018;50:637–54.
  • Marco EM, Velarde E, Llorente R, et al. Disrupted Circadian Rhythm as a Common Player in Developmental Models of Neuropsychiatric Disorders. Curr Top Behav Neurosci 2016;29:155–81.
  • Manoogian ENC, Panda S. Circadian rhythms, time-restricted feeding, and healthy aging. Ageing Res Rev 2017;39:59–67.
  • Duffy JF, Zitting K-M, Chinoy ED. Aging and Circadian Rhythms. Sleep Med Clin 2015;10:423–34.
  • Firsov D, Bonny O. Circadian rhythms and the kidney. Nat Rev Nephrol 2018;14:626–35.
  • Ohashi N, Isobe S, Ishigaki S, Yasuda H. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney. Hypertens Res 2017;40:413–22.
  • Masri S, Sassone-Corsi P. The emerging link between cancer, metabolism, and circadian rhythms. Nat Med 2018;24:1795–803.
  • Reszka E, Zienolddiny S. Epigenetic Basis of Circadian Rhythm Disruption in Cancer. Methods Mol Biol 2018;1856:173–201.
  • Gibbs JE, Blaikley J, Beesley S, et al. The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc Natl Acad Sci USA 2012;109:582–87.
  • Hirota T, Kay SA. Identification of small-molecule modulators of the circadian clock. Meth. Enzymol 2015;551:267–82.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.